Articles on Gene Editing

Gene editing technologies, including CRISPR, are transforming biotech research and therapeutic development. This section covers precision tools, evolving gene editing platforms, and the ethical and regulatory considerations shaping the field.



Featured Article

IND Approval for Solid Tumor Therapy Using KACTUS Cas9 Enzyme


In a groundbreaking development for the biotech industry, KACTUS's GMP-grade Cas9 has critically helped Yizun Bio secure IND clearance for a universal solid tumor cell therapy. Yizun Bio’s CNK-UT002 cell injection, an innovative allogeneic T cell therapy designed for advanced solid tumors such as liver cancer and melanoma,


Browse our products:

Breaking News: KACTUS GMP-Grade Cas9 Powers Bioheng’s Breakthrough IND Clearance for Next-Gen UCAR-T Therapy

March 5, 2025

4 min read

NK Cell Therapy Gets IND FDA Clearance with AccuBase® Base Editor from KACTUS

November 21, 2024

5 min read

2024 Milestones in CRISPR Clinical Pipelines

November 11, 2024

5 min read

Base Editing Technology Leads a New Chapter in Drug Development

February 14, 2024

5 min read

Have questions? Get in touch!

support@kactusbio.us